![Dealing with the combinatorial complexity of protein engineering: bi- and multi-specifics, TCRs and CAR Ts](https://img.swapcard.com/?u=https%3A%2F%2Fcdn-api.swapcard.com%2Fpublic%2Fimages%2F9c6b064e94c84ba78c6bd0f1cbc7c158.png&q=0.8&m=fit&h=720)
![](https://img.swapcard.com/?u=https%3A%2F%2Fcdn-api.swapcard.com%2Fpublic%2Fimages%2F9c6b064e94c84ba78c6bd0f1cbc7c158.png&q=0.8&m=crop&h=720)
Dealing with the combinatorial complexity of protein engineering: bi- and multi-specifics, TCRs and CAR Ts
Monday, November 2, 2020 3:00 PM to 3:20 PM · 20 min. (Africa/Abidjan)
World Immunotherapy Congress
Cell and gene immunotherapy
Presentation
Information
- New technology platform that fully automates molecular design, as well as the integrated assessment of potency, efficacy, and developability profiling of large panels of bispecific candidates
- Use cases showing the systematic cloning, expression, purification, and characterization of complex multi-specific, CAR T and TCR modalities, with a focus on immuno-oncology applications
Jessy Sheng, Ph.D., Scientific Consultant, Genedata